These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3300294)

  • 21. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
    Tinawi M; Miller L; Bastani B
    Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.
    Ferraresso M; Turolo S; Belinghieri M; Tirelli AS; Grillo P; Groppali E; Edefonti A; Ghio L
    Pediatr Transplant; 2012 Sep; 16(6):658-63. PubMed ID: 22765024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin.
    Pei Y; Chan C; Cattran D; Cardella C; Zaltzman J; Lopez M; Tong J; Schachter R; Maurer J
    J Lab Clin Med; 1995 Jan; 125(1):113-9. PubMed ID: 7822939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relations of gingival hypertrophy and blood levels of cyclosporin A in patients with renal transplants].
    Fuiano G; Pacchiano G; Lotito MA; Vaia E; Matarasso S; Andreucci VE
    Ann Ital Med Int; 1989; 4(3):161-6. PubMed ID: 2702027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK; Leichtman AB; Blake DS; Schmouder RL; Lown KS; Annesley TM; Watkins PB
    Transplantation; 1994 Jun; 57(12):1736-41. PubMed ID: 8016878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
    Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
    Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
    Lancet; 1982 Jul; 2(8289):57-60. PubMed ID: 6123806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
    Dominguez J; Kompatzki A; Velasco A; Turpaud F; Norambuena R; Arenas J; Pais E; Llanos R; Cortes-Monroy G
    Transplant Proc; 2005 Oct; 37(8):3358-60. PubMed ID: 16298595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of a cyclosporin-ketoconazole combination: making renal transplantation affordable in developing countries.
    Gerntholtz T; Pascoe MD; Botha JF; Halkett J; Kahn D
    Eur J Clin Pharmacol; 2004 May; 60(3):143-8. PubMed ID: 15083250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of transplant aspiration cytology on management of cyclosporine A-treated renal transplant recipients.
    Yussim A; Shapira Z; Shmueli D; Heilbronn YD; Kaufman L; Servadio C
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1658-9. PubMed ID: 3274399
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients.
    Covic A; Mardare N; Gusbeth-Tatomir P; Buhaescu I; Goldsmith DJ
    Kidney Int; 2005 Feb; 67(2):732-7. PubMed ID: 15673323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A.
    Makover D; Freundlich B; Zurier RB
    J Rheumatol; 1988 Jan; 15(1):117-9. PubMed ID: 3280791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
    J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile refeeding after liver transplantation and avoidance of intravenous cyclosporine.
    Merion RM; Gorski DH; Burtch GD; Turcotte JG; Colletti LM; Campbell DA
    Surgery; 1989 Oct; 106(4):604-9; discussion 609-10. PubMed ID: 2799635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
    Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.